<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01527162</url>
  </required_header>
  <id_info>
    <org_study_id>K23HD060764-03B</org_study_id>
    <secondary_id>K23HD060764-03</secondary_id>
    <nct_id>NCT01527162</nct_id>
  </id_info>
  <brief_title>Orthotics in Ambulatory Cerebral Palsy</brief_title>
  <acronym>SAFO</acronym>
  <official_title>Relationship of Orthotics to Activity and Participation in Children With Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seattle Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will examine the effect of solid ankle foot orthoses (SAFO) on day to day
      walking activity and life participation of ambulatory children with cerebral palsy. The
      investigators propose that SAFO have not effect on levels of walking and life participation
      versus not wearing the SAFO.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a repeated measures trial with randomization of intervention in a cross over design
      which will quantify daily walking and physical activity levels for children with cerebral
      palsy (CP) with and without use of a solid ankle foot orthotic (SAFO). Current orthotic
      management guidelines are based primarily on evidence that SAFO use positively impacts body
      function and structure in clinic and lab based observations of activity and movement. Prior
      research has determined that wearing a SAFO improves different aspects of gait and mobility
      (stride and step length, single limb stance, velocity) for children with CP. However, these
      studies have been limited by small sample sizes, lack of comparison groups, inconsistency of
      orthotic fabrication, lack of clear and simple outcome measures and/or randomized control
      designs. No prior studies have evaluated the effect of SAFO use on activity performance
      outcomes.

      The purpose of this study is to determine the effect of wearing or not wearing current SAFO
      on a child's walking ability, participation in common life activities, and gait. Children
      ages 2 - &lt; 10 years who have bilateral cerebral palsy, dynamic equinus gait deformity, and
      wear bilateral SAFOs fabricated by Cascade DAFO will be approached for participation.
      Enrolled children are randomly assigned to either wear or not wear their SAFOs for a 14 day
      intervention period. After this period is over, children will then do the opposite for a
      second 14 day intervention period. Children attend three study visits; at enrollment, after
      the first intervention period is over, and after the second intervention period. At the first
      visit, parents and children (where applicable) complete questionnaires regarding their
      participation in common life activities in the prior 7 days, and complete a walking
      evaluation. Children wear a StepWatch accelerometer during each intervention period, which
      counts the number of steps the child takes and the time each step was taken. After the second
      intervention period is complete, the child's participation in the research study is complete.
      One home visit is conducted at the end of each intervention period, where the questionnaires
      are repeated, and the StepWatch is downloaded and/or re - calibrated per protocol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Walking Activity Levels</measure>
    <time_frame>average of 5 days of second week of intervention</time_frame>
    <description>Daily walking activity will be measured with the StepWatch accelerometer documenting average strides/day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Scale for Kids - Performance Version (ASKp)</measure>
    <time_frame>previous 7 day reference</time_frame>
    <description>Physical activity will be by parental report of Physical Activities Scale for Kids performance version (ASKp) survey- total score. Scale ranges from 0 to 100 with higher scores representing more physical activity. A score of 100 on this criterion referenced evalutive measure is consistent with physical activity like that of a typically developing 5 year old.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Life Habits for Children (LIFE-H)</measure>
    <time_frame>previous 7 day reference</time_frame>
    <description>Participation in habits of daily life will be by parental report of the Life Habits questionnaire(Life-H for children) by the weighted total score on a scale of 0 to 9, with a higher score representing more participation in habits of daily life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>SAFO worn</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Child wears their prescribed SAFO for 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAFO not worn</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Child does not wear the prescribed SAFO for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SAFO worn</intervention_name>
    <description>Child wears their prescribed SAFO for 14 days by random assignment</description>
    <arm_group_label>SAFO worn</arm_group_label>
    <other_name>Solid ankle foot orthoses (SAFO)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SAFO not worn</intervention_name>
    <description>Child does not wear their prescirbed SAFO for 14 days by random assignment</description>
    <arm_group_label>SAFO worn</arm_group_label>
    <other_name>Solid ankle foot orthoses (SAFO)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 2 to &lt;10 years

          2. Gross Motor Function Classification Scale Score of 1 - 3 (ambulatory)

          3. Diagnosed with bilateral cerebral palsy

          4. Has dynamic equinus gait deformity, defined as PROM to neutral, with equinus weight
             bearing pattern.

          5. Wears bilateral SAFO more than 8 hours per day for more than one month.

          6. Has a SAFO prescription of ankle at neutral (zero plantarflexion, with &lt;10 degrees
             dorsiflexion).

          7. The primary goal of the SAFO is to facilitate balance and walking

          8. Has SAFOs fabricated by Cascade DAFO, Ferndale, WA.

          9. Parent and child are willing to discontinue SAFO use for two weeks.

        Exclusion Criteria:

          1. Has visual impairment which limits physical activity.

          2. Has had lower extremity Botox injections in the past 3 months.

          3. Is expected to require changes to medications treating the movement disorder during
             the study period.

          4. Has an uncontrolled seizure disorder which impacts mobility skills.

          5. Has had neurosurgical or orthopedic surgeries in the past 6 months.

          6. Has had other surgeries or procedures in the past two weeks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>9 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristie Bjornson, PT, PhD, PCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle Children's</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seattle Childrens Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2012</study_first_submitted>
  <study_first_submitted_qc>February 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2012</study_first_posted>
  <results_first_submitted>November 16, 2015</results_first_submitted>
  <results_first_submitted_qc>February 3, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 4, 2016</results_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seattle Children's Hospital</investigator_affiliation>
    <investigator_full_name>Kristie Bjornson</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cerebral palsy</keyword>
  <keyword>orthotics</keyword>
  <keyword>solid ankle foot orthoses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SAFO Worn First, Then Not Worn</title>
          <description>Child wears their prescribed SAFO for 14 days by random assignment and then not worn</description>
        </group>
        <group group_id="P2">
          <title>SAFO NOT Worn First, Then Worn</title>
          <description>Child does not wear their prescirbed SAFO for 14 days by random assignment, then worn</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>ages 3.0 to 5.8 years, mean age 4.3 years, spastic diplegia cerebral palsy, all wearing current AFO bilaterally to enhance walking activity</population>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>We used a randomized cross-over design with eleven children with bilateral 9 CP, mean age 4.3 years. Subjects were randomized to their current SAFO worn or SAFO not worn for 2 weeks and then crossed over.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.3" lower_limit="3.0" upper_limit="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Walking Activity Levels</title>
        <description>Daily walking activity will be measured with the StepWatch accelerometer documenting average strides/day.</description>
        <time_frame>average of 5 days of second week of intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SAFO Worn</title>
            <description>Child wears their prescribed SAFO for 14 days
SAFO worn: Child wears their prescribed SAFO for 14 days by random assignment
SAFO not worn: Child does not wear their prescirbed SAFO for 14 days by random assignment</description>
          </group>
          <group group_id="O2">
            <title>SAFO Not Worn</title>
            <description>Child does not wear the prescribed SAFO for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Walking Activity Levels</title>
          <description>Daily walking activity will be measured with the StepWatch accelerometer documenting average strides/day.</description>
          <units>average total strides/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4660" spread="1421"/>
                    <measurement group_id="O2" value="4897" spread="1438"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physical Activity Scale for Kids - Performance Version (ASKp)</title>
        <description>Physical activity will be by parental report of Physical Activities Scale for Kids performance version (ASKp) survey- total score. Scale ranges from 0 to 100 with higher scores representing more physical activity. A score of 100 on this criterion referenced evalutive measure is consistent with physical activity like that of a typically developing 5 year old.</description>
        <time_frame>previous 7 day reference</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SAFO Worn</title>
            <description>Child wears their prescribed SAFO for 14 days</description>
          </group>
          <group group_id="O2">
            <title>SAFO Not Worn</title>
            <description>Child does not wear the prescribed SAFO for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Physical Activity Scale for Kids - Performance Version (ASKp)</title>
          <description>Physical activity will be by parental report of Physical Activities Scale for Kids performance version (ASKp) survey- total score. Scale ranges from 0 to 100 with higher scores representing more physical activity. A score of 100 on this criterion referenced evalutive measure is consistent with physical activity like that of a typically developing 5 year old.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.08" spread="11.64"/>
                    <measurement group_id="O2" value="49.45" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>= 0.14</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Life Habits for Children (LIFE-H)</title>
        <description>Participation in habits of daily life will be by parental report of the Life Habits questionnaire(Life-H for children) by the weighted total score on a scale of 0 to 9, with a higher score representing more participation in habits of daily life.</description>
        <time_frame>previous 7 day reference</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SAFO Worn</title>
            <description>Child wears their prescribed SAFO for 14 days</description>
          </group>
          <group group_id="O2">
            <title>SAFO Not Worn</title>
            <description>Child does not wears their prescribed SAFO for 14 days</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Life Habits for Children (LIFE-H)</title>
          <description>Participation in habits of daily life will be by parental report of the Life Habits questionnaire(Life-H for children) by the weighted total score on a scale of 0 to 9, with a higher score representing more participation in habits of daily life.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.71" spread="2.0"/>
                    <measurement group_id="O2" value="5.11" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Paired Wilcoxon Sign Rank TEst</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;.54</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>= 0.20</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>SAFO Worn</title>
          <description>SAFO worn: Child wears their prescirbed SAFO for 14 dyas by random assignment</description>
        </group>
        <group group_id="E2">
          <title>SAFO Not Worn</title>
          <description>SAFO not worn: Child does ont wear their prescribed SAFO for 14 days by random assignment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kristie Bjornson, PhD, PT</name_or_title>
      <organization>Seattle Children's Research Institute</organization>
      <phone>206 884-2066</phone>
      <email>kristie.bjornson@seattlechildrens.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

